Lataa...
High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors
There are currently no established second- and later-line therapies for postmenopausal women with hormone receptor-positive advanced or metastatic breast cancer. We examined the efficacy of high-dose toremifene (HD-TOR) for this patient group and whether aromatase inhibitor (AI) resistance influence...
Tallennettuna:
| Julkaisussa: | Int J Breast Cancer |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7037483/ https://ncbi.nlm.nih.gov/pubmed/32099680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7156574 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|